-
公开(公告)号:EP1933851A4
公开(公告)日:2008-09-24
申请号:EP05793864
申请日:2005-09-07
申请人: BEBAAS INC
发明人: BROWN CHAD
IPC分类号: A61K31/714 , A61K9/12 , A61K45/06 , A61P3/02 , A61P7/06 , A61P11/06 , A61P25/28 , A61P29/00 , A61P37/04 , A61P37/08
CPC分类号: A61K9/0056 , A61K9/006 , A61K9/0073 , A61K31/714 , A61K2300/00
-
公开(公告)号:EP1933851A1
公开(公告)日:2008-06-25
申请号:EP05793864.9
申请日:2005-09-07
申请人: Bebaas, Inc.
发明人: BROWN, Chad
IPC分类号: A61K31/714 , A61K9/12
CPC分类号: A61K9/0056 , A61K9/006 , A61K9/0073 , A61K31/714 , A61K2300/00
摘要: The present invention provides improved vitamin B12 compositions containing a mixture of vitamin B12 analogues that are better absorbed into the bloodstream of a patient with vitamin B12 deficiency, preferably via their mucosal membranes and also discusses convenient and inexpensive delivery methods for these compositions without the discomfort of subcutaneous or intramuscular injections.
-
公开(公告)号:EP1773354A4
公开(公告)日:2010-05-05
申请号:EP05773512
申请日:2005-07-20
申请人: BEBAAS INC
发明人: BROWN CHAD
CPC分类号: A61K9/0017 , A61K9/0019 , A61K31/714
-
公开(公告)号:EP1773354A2
公开(公告)日:2007-04-18
申请号:EP05773512.8
申请日:2005-07-20
申请人: Bebaas, Inc.
发明人: BROWN, Chad
CPC分类号: A61K9/0017 , A61K9/0019 , A61K31/714
摘要: The present invention provides improved vitamin B12 compositions containing a mixture of vitamin B12 analogues that are better absorbed into the bloodstream of a patient with vitamin B12 deficiency, preferably via their mucosal membranes and also discusses convenient and inexpensive delivery methods for these compositions without the discomfort of subcutaneous or intramuscular injections.
-
公开(公告)号:EP1979487A4
公开(公告)日:2010-05-05
申请号:EP07710331
申请日:2007-01-26
申请人: BEBAAS INC
发明人: BROWN CHAD
CPC分类号: A61K31/714 , A61K33/00 , A61K2300/00
-
公开(公告)号:EP1979487A2
公开(公告)日:2008-10-15
申请号:EP07710331.5
申请日:2007-01-26
申请人: Bebaas, Inc.
发明人: BROWN, Chad
CPC分类号: A61K31/714 , A61K33/00 , A61K2300/00
摘要: Compositions are provided that contain a combination of a nitric oxide- cobalamin complex along with at least one cobalamin drug conjugate, together with methods of use for treatment of neoplastic disease.
-
-
-
-
-